Skip to main content
Top
Published in: BMC Neurology 1/2022

Open Access 01-12-2022 | Neuromyelitis Optica Spectrum Disease | Case report

Autoimmune glial fibrillary acidic protein astrocytopathy presented as isolated area postrema symdrome: a case report

Authors: Jing Dang, Shengsuo Lei, Jihua Chen

Published in: BMC Neurology | Issue 1/2022

Login to get access

Abstract

Background

Area postrema syndrome (APS) as the isolated manifestation in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy has been rarely reported.

Case presentation

A 61-year-old male patient presented with intractable hiccup. He was first admitted to the department of Gastroenterology because he had no symptoms other than hiccup. Then he was diagnosed with possible digestive system disease and started on treatment. 2 weeks later, his symptom didn’t improve at all. After consultation, the patient was referred to our department. Cerebrospinal fluid (CSF) analysis revealed lymphocytes pleocytosis, elevated protein level. Cell-based assays demonstrated GFAP antibodies in blood and CSF. His symptom improved with steroid pulse therapy (methylprednisolone, 1 g for 5 days), followed by a gradual tapering of oral prednisolone. Three months after the initial presentation, he showed no relapses.

Conclusions

We report atypical manifestation of autoimmune GFAP astrocytopathy which presented as APS, suggesting that autoimmune GFAP astrocytopathy should be added to the list of possible cause of APS.
Literature
1.
go back to reference Fang B, McKeon A, Hinson SR, et al. Autoimmune glial fibrillary acidic protein Astrocytopathy. A Novel Meningoencephalomyelitis. JAMA Neurol. 2016;73:1297–307.CrossRef Fang B, McKeon A, Hinson SR, et al. Autoimmune glial fibrillary acidic protein Astrocytopathy. A Novel Meningoencephalomyelitis. JAMA Neurol. 2016;73:1297–307.CrossRef
2.
go back to reference Kunchok A, Zekeridou A, McKeon A. Autoimmune glial fibrillary acidic protein astrocytopathy. Curr Opin Neurol. 2019;32:452–8.CrossRef Kunchok A, Zekeridou A, McKeon A. Autoimmune glial fibrillary acidic protein astrocytopathy. Curr Opin Neurol. 2019;32:452–8.CrossRef
3.
go back to reference Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177–89.CrossRef Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177–89.CrossRef
4.
go back to reference Ciron J, Sourdrille F, Biotti D, et al. Area postrema syndrome: another feature of anti-GFAP encephalomyelitis. Mult Scler. 2020;26(2):253–5.CrossRef Ciron J, Sourdrille F, Biotti D, et al. Area postrema syndrome: another feature of anti-GFAP encephalomyelitis. Mult Scler. 2020;26(2):253–5.CrossRef
5.
go back to reference Gao X, Tang Y, Yang GD, et al. Autoimmune glial fibrillary acidic protein Astrocytopathy associated with area Postrema syndrome: a case report. Front Neurol. 2021;12:803116.CrossRef Gao X, Tang Y, Yang GD, et al. Autoimmune glial fibrillary acidic protein Astrocytopathy associated with area Postrema syndrome: a case report. Front Neurol. 2021;12:803116.CrossRef
6.
go back to reference Misu T, Fujihara K, Nakashima I, et al. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology. 2005;65:1479–82.CrossRef Misu T, Fujihara K, Nakashima I, et al. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology. 2005;65:1479–82.CrossRef
7.
go back to reference Apiwattanakul M, Popescu BF, Matiello M, et al. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol. 2010;68:757–61.CrossRef Apiwattanakul M, Popescu BF, Matiello M, et al. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol. 2010;68:757–61.CrossRef
8.
go back to reference Popescu BF, Lennon VA, Parisi JE, et al. Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology. 2011;76:1229–37.CrossRef Popescu BF, Lennon VA, Parisi JE, et al. Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology. 2011;76:1229–37.CrossRef
9.
go back to reference Shan F, Long Y, Qiu W. Autoimmune glial fibrillary acidic protein Astrocytopathy: a review of the literature. Front Immunol. 2018;9:2802.CrossRef Shan F, Long Y, Qiu W. Autoimmune glial fibrillary acidic protein Astrocytopathy: a review of the literature. Front Immunol. 2018;9:2802.CrossRef
10.
go back to reference Flanagan EP, Hinson SR, Lennon VA, et al. Glial fibrillary acidic protein ImmunoglobulinG as biomarker of autoimmune Astrocytopathy: analysis of 102 patients. Ann Neurol. 2017;81:298–309.CrossRef Flanagan EP, Hinson SR, Lennon VA, et al. Glial fibrillary acidic protein ImmunoglobulinG as biomarker of autoimmune Astrocytopathy: analysis of 102 patients. Ann Neurol. 2017;81:298–309.CrossRef
11.
go back to reference Yang X, Liang J, et al. Treatment of autoimmune glial fibrillary acidic protein astrocytopathy: follow-up in 7 cases. Neuroimmunomodulation. 2017;24:113–9.CrossRef Yang X, Liang J, et al. Treatment of autoimmune glial fibrillary acidic protein astrocytopathy: follow-up in 7 cases. Neuroimmunomodulation. 2017;24:113–9.CrossRef
12.
go back to reference Long Y, Liang J, Xu H, et al. Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study. Eur J Neurol. 2018;25:477–83.CrossRef Long Y, Liang J, Xu H, et al. Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study. Eur J Neurol. 2018;25:477–83.CrossRef
Metadata
Title
Autoimmune glial fibrillary acidic protein astrocytopathy presented as isolated area postrema symdrome: a case report
Authors
Jing Dang
Shengsuo Lei
Jihua Chen
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2022
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-022-02802-2

Other articles of this Issue 1/2022

BMC Neurology 1/2022 Go to the issue